NCI | Technology Transfer

HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION

Read more about HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION

Canada
3194229
Filed on 2023-03-29

HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION

Read more about HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION

Japan
2023-520143
Filed on 2023-03-31

ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS

Read more about ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS

Japan
2023-020373
Filed on 2023-02-13

METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD

Read more about METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD

US Application 18/174,928
Filed on 2023-02-27

Peptide-Based Methods For Treating Pancreatic Cancer

Read more about Peptide-Based Methods For Treating Pancreatic Cancer

Ireland
15788259.8
Filed on 2015-10-13

Peptide-Based Methods For Treating Pancreatic Cancer

Read more about Peptide-Based Methods For Treating Pancreatic Cancer

United Kingdom
15788259.8
Filed on 2015-10-13

Peptide-Based Methods For Treating Pancreatic Cancer

Read more about Peptide-Based Methods For Treating Pancreatic Cancer

France
15788259.8
Filed on 2015-10-13

Peptide-Based Methods For Treating Pancreatic Cancer

Read more about Peptide-Based Methods For Treating Pancreatic Cancer

Germany
15788259.8
Filed on 2015-10-13

Peptide-Based Methods For Treating Pancreatic Cancer

Read more about Peptide-Based Methods For Treating Pancreatic Cancer

Switzerland
15788259.8
Filed on 2015-10-13

Anti-Mutated Kras T Cell Receptors

Read more about Anti-Mutated Kras T Cell Receptors

Australia
2023200614
Filed on 2023-02-07

Subscribe to NCI